Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$87.44 - $125.0 $143 Million - $205 Million
-1,639,901 Closed
0 $0
Q2 2020

Aug 17, 2020

SELL
$58.39 - $89.31 $128 Million - $196 Million
-2,196,331 Reduced 57.25%
1,639,901 $146 Million
Q1 2020

May 15, 2020

BUY
$51.57 - $106.62 $198 Million - $409 Million
3,836,232 New
3,836,232 $239 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.27B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Sb Investment Advisers (Uk) LTD Portfolio

Follow Sb Investment Advisers (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sb Investment Advisers (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sb Investment Advisers (Uk) LTD with notifications on news.